The addition of hypomethylating agents to low-intensity induction chemotherapy does not improve outcomes in elderly acute myeloid leukemia patients: a single-center retrospective study

HIGHLIGHTS

  • who: Dan Liu and collaborators from the Department of Hematology, Anhui Provincial Hospital, WanNan Medical College, Wenchang Xi Road No22, Wuhu, China University of Science and Technology of China, Lujiang Road No17, Hefei, China have published the research work: The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study, in the Journal: Medicina 2023, 59, 114. of 31/03/2022
  • what: This study showed that the addition of HMA to low-intensity induction prognosis in elderly AML patients who are . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?